Beibei Zhao

Company: ProMIS Neurosciences

Job title: Director, Research Programs

Seminars:

– Preclinical Validation of RACK1 as a Novel Target for Sporadic ALS 2:10 pm

Explaining RACK1 co-aggregation with TDP-43 in postmortem spinal cord tissues of sporadic and C9orf72 ALS patients and cultured cells Outlining preclinical results from RACK1 knock-down in in vitro cultured cells Showcasing results from RACK1 knock-down preclinical testing in in vivo transgenic D. melanogaster ALS modelsRead more

day: Day One PM